Data in question: A survey of European biobank professionals on ethical, legal and societal challenges of biobank research

Abstract

Biobanks have evolved, and their governance procedures have undergone important transformations. Our paper examines this issue by focusing on the perspective of the professionals working in management or scientific roles in research-based biobanks, who have an important impact on shaping these transformations. In particular, it highlights that recent advances in molecular medicine and genomic research have raised a range of ethical, legal and societal implications (ELSI) related to biobank-based research, impacting directly on regulations and local practices of informed consent (IC), private-public partnerships (PPPs), and engagement of participants. In our study, we investigate the ways that these concerns influence biobanking practices and assess the level of satisfaction of the cross-national biobanking research communities with the ELSI related procedures that are currently in place. We conducted an online survey among biobankers and researchers to investigate secondary use of data, informing and/or re-contacting participants, sharing of data with third parties from industry, participant engagement, and collaboration with industrial partners. Findings highlight the need for a more inclusive and transparent biobanking practice where biobanks are seen in a more active role in providing information and communicating with participants; the need to improve the current IC procedures and the role of biobanks in sharing of samples and data with industry partners and different countries, and the need for practical, tangible and hands-on ethical and legal guidance.

The Skeleton in the Closet: Faults and Strengths of Public Versus Private Genetic Biobanks

“…Lack of trust in this initiative seems to be mainly related to public concerns about transparency, confidentiality and privacy. The interest in comparing these two types of biobanks also derives from the fact that, recently, often effective models of collaboration between the public and private sectors have developed, so different studies on how such collaborations can take off have become interesting from the point of view of ethical, legal and societal implications (ELSI) [ 7 ].…”

Building and sustaining collaborative platforms in genomics and biobanks for health innovation

“…However, patients and governments value the outputs of research differently, and this value can be difficult to capture in traditional economic assessments. Awareness of the value to different stakeholders of the benefits of innovations in genomics is important as it can help produce mutually agreeable models (Ginsburg and Phillips, 2018 [102]).…”

Ever-changing Big Science and Research Infrastructures: Evolving European Union policy

“…These new types of instrumentation come with new organizational and political aspects that are not present in the cases of traditional Big Machines. One such question is about the ethical, legal and social aspects of Big Science and RIs which are particularly relevant in the case of data infrastructures of life sciences that rely on patient data (Goisauf et al 2019).…”